Related Experiment Video

Updated: Jul 25, 2026

A Method for Measuring RNA N6-methyladenosine Modifications in Cells and Tissues
08:56

A Method for Measuring RNA N6-methyladenosine Modifications in Cells and Tissues

Published on: December 5, 2016

The biological effects of N3-methyladenine

Gilberto Fronza1, Barry Gold

  • 1Mutagenesis Laboratory, National Cancer Research Institute (IST), L.go R. Benzi, 10, 16132-Genova, Italy.

Journal of Cellular Biochemistry
|January 27, 2004
PubMed

Insights

Researchers developed novel agents to selectively methylate DNA at adenine N3, aiming to kill tumor cells while minimizing harmful mutations. This targeted DNA damage offers a safer cancer therapy approach.

Area of Science:

  • Molecular Biology
  • Cancer Therapeutics
  • DNA Damage and Repair

Background:

  • Alkylating agents are used in cancer therapy but cause toxic and mutagenic DNA lesions.
  • Therapy-induced mutations increase secondary cancer risk in patients.
  • Targeting specific DNA damage is a strategy to improve cancer treatment efficacy and safety.

Purpose of the Study:

  • To develop novel agents that selectively methylate DNA at the N3-position of adenine.
  • To investigate the potential of N3-methyladenine as a tumor-selective cytotoxic lesion.
  • To evaluate the toxicity and mutagenicity of these novel agents.

Main Methods:

  • Synthesis of novel methylating agents.
  • Treatment of bacterial, yeast, and mammalian cell systems.
  • Assessment of DNA polymerase stalling and downstream cellular effects.
  • Evaluation of cytotoxicity and mutagenicity.

Main Results:

  • The developed agents selectively generate N3-methyladenine lesions in DNA.
  • N3-methyladenine is proposed to halt DNA polymerase, initiating cell death cascades.
  • The compound Me-lex, used to generate N3-methyladenine, shows varying toxicity and mutagenicity across different systems.

Conclusions:

  • Selective N3-methylation of adenine represents a promising strategy for cancer therapy.
  • Minimizing mutagenic lesions could reduce secondary cancer risks associated with DNA-damaging agents.
  • Further research into the mechanisms of N3-methyladenine biological activity is warranted.

More Related Videos

Exploring the Arginine Methylome by Nuclear Magnetic Resonance Spectroscopy07:02

Exploring the Arginine Methylome by Nuclear Magnetic Resonance Spectroscopy

Published on: December 16, 2021

Dot Blot Assay for Detecting Global N6-Methyladenosine RNA Modification Levels08:40

Dot Blot Assay for Detecting Global N6-Methyladenosine RNA Modification Levels

Published on: February 6, 2026

Related Concept Videos

RNA Editing02:23

RNA Editing

RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
2° Amines to N-Nitrosamines: Reaction with NaNO201:20

2° Amines to N-Nitrosamines: Reaction with NaNO2

Secondary amines react with nitrous acid to form N-nitrosamines, as depicted in Figure 1. Nitrous acid, a weak and unstable acid, is formed in situ from an aqueous solution of sodium nitrite and strong acids, such as hydrochloric acid or sulfuric acid, in cold conditions. In the presence of an acid, the nitrous acid gets protonated. The subsequent loss of water results in the formation of the electrophile known as nitrosonium ion.
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
Phase II Reactions: Methylation Reactions01:17

Phase II Reactions: Methylation Reactions

Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
Biosynthesis of Nucleic Acids01:28

Biosynthesis of Nucleic Acids

Nucleic acid biosynthesis is a fundamental biochemical process that produces the purine and pyrimidine nucleotides essential for DNA and RNA synthesis. This pathway maintains a balanced nucleotide pool, preventing imbalances that could jeopardize genetic integrity and cellular function. Given the crucial role of nucleotides, their synthesis is tightly regulated to ensure proper cellular homeostasis.Purine BiosynthesisThe biosynthesis of purine nucleotides begins with ribose-5-phosphate, a...